Catatonia

Advances in Psychiatric Treatment

Volumn 13, Issue 1, 2007, Pages 51-59

  Rajagopal, Sundararajan ^a,b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 AMINOBUTYRIC ACID; AMANTADINE; BENZODIAZEPINE; BROMOCRIPTINE; CARBAMAZEPINE; CIPROFLOXACIN; CLOZAPINE; COCAINE; DANTROLENE; DIAZEPAM; DOPAMINE; LITHIUM; LORAZEPAM; MEMANTINE; NEUROLEPTIC AGENT; ZOLPIDEM;

CATALEPSY; CATATONIA; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DEFENSE MECHANISM; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG MECHANISM; DRUG RESPONSE; ECHOLALIA; ELECTROCONVULSIVE THERAPY; HUMAN; LOW DRUG DOSE; LUNG EMBOLISM; MOOD DISORDER; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; PATHOGENESIS; PROGNOSIS; PUERPERAL PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SPEECH DISORDER; STEREOTYPY; STUPOR; TONIC IMMOBILITY;

EID: 38549175301     PISSN: 13555146     EISSN: None     Source Type: Journal    
DOI: 10.1192/apt.bp.106.002360     Document Type: Review

References (65)

1. Abrams, R. & Taylor, M. A. (1976) Catatonia. A prospective clinical study. Archives of General Psychiatry, 33, 579-581.
2. Akhtar, S. & Ahmad, H. (1993) Ciprofloxacin-induced catatonia. Journal of Clinical Psychiatry, 54, 115-116.
3. Alisky, J. M. (2004) Is the immobility of advanced dementia a form of lorazepam-responsive catatonia? American Journal of Alzheimer's Disease and Other Dementias, 19, 213-214.
4. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA.
5. Barnes, M. P., Saunders, M., Walls, T. J., et al (1986) The syndrome of Karl Ludwig Kahlbaum. Journal of Neurology, Neurosurgery and Psychiatry, 49, 991-996.
6. Benegal, V., Hingorani, S. & Khanna, S. (1993) Idiopathic catatonia: validity of the concept. Psychopathology, 26, 41-46.
7. Bush, G., Fink, M., Petrides, G., et al (1996) Catatonia. I. Rating scale and standardized examination. Acta Psychiatrica Scandinavica, 93, 129-136.
8. Castillo, E., Rubin, R. T. & Holsboer-Trachsler, E. (1989) Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome. American Journal of Psychiatry, 146, 324-328.
9. Climo, L. H. (1985) Treatment-resistant catatonic stupor and combined lithium-neuroleptic therapy: a case report. Journal of Clinical Psychopharmacology, 5, 166-170.
10. Dabholkar, P. D. (1988) Use of ECT in hysterical catatonia. A case report and discussion. British Journal of Psychiatry, 153, 246-247.
11. Davis, E. J. & Borde, M. (1993) Wilson's disease and catatonia. British Journal of Psychiatry, 162, 256-259.
12. Dhossche, D. M. (2004) Autism as early expression of catatonia. Medical Science Monitor, 10, 31-39.
13. Fink, M. (1996) Neuroleptic malignant syndrome and catatonia: one entity or two? Biological Psychiatry, 39, 1-4.
14. Gingrich, J. A., Rudnick-Levin, F., Almeida, C., et al (1998) Cocaine and catatonia. American Journal of Psychiatry, 155, 1629.
15. Hare, D. J. & Malone, C. (2004) Catatonia and autistic spectrum disorders. Autism, 8, 183-195.
16. Hesslinger, B., Walden, J. & Normann, C. (2001) Acute and long-term treatment of catatonia with risperidone. Pharmacopsychiatry, 34, 25-26.
17. Kahlbaum, K. L. (1874) Die Katatonie oder das Spannungsirresein. August Hirschwald.
18. Kirubakaran, V., Sen, S. & Wilkinson, C. B. (1987) Catatonic stupor: unusual manifestation of temporal lobe epilepsy. Psychiatric Journal of the University of Ottawa, 12, 244-246.
19. Kritzinger, P. R. & Jordaan, G. P. (2001) Catatonia: an open prospective series with carbamazepine. International Journal of Neuropsychopharmacology, 4, 251-257.
20. Lai, J. Y. & Huang, T. L. (2004) Catatonic features noted in patients with post-partum mental illness. Psychiatry and Clinical Neurosciences, 58, 157-162.
21. Lauer, M., Schirrmeister, H., Gerhard, A., et al (2001) Disturbed neural circuits in a subtype of chronic catatonic schizophrenia demonstrated by F-18-FDG-PET and F-18-DOPA-PET. Journal of Neural Transmission, 108, 661-670.
22. Lee, J. W. & Schwartz, D. L. (1997) Catatonia associated with hyponatremia. Neuropsychiatry, Neuropsychology and Behavioral Neurology, 10, 63-64.
23. Leonhard, K. (1979) The Classification of Endogenous Psychoses (5th edn). Transl. R. Berman. Irvington.
24. Lim, J., Yagnik, P., Schraeder, P., et al (1986) Ictal catatonia as a manifestation of nonconvulsive status epilepticus. Journal of Neurology, Neurosurgery and Psychiatry, 49, 833-836.
25. Louis, E. D. & Pflaster, N. L. (1995) Catatonia mimicking nonconvulsive status epilepticus. Epilepsia, 36, 943-945.
26. Lund, C. E., Mortimer, A. M., Rogers, D., et al (1991) Motor, volitional and behavioural disorders in schizophrenia. 1: Assessment using the Modified Rogers Scale. British Journal of Psychiatry, 158, 323-327.
27. Mann, S. C., Auriacombe, M., Macfadden, W., et al (2001) [Lethal catatonia: clinical aspects and therapeutic intervention. A review of the literature] (in French). L'Encéphale, 27, 213-216.
28. Masi, G., Mucci, M. & Floriani, C. (2002) Acute catatonia after a single dose of ecstasy. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 892.
29. Mastain, B., Vaiva, G., Guerouaou, D., et al (1995) [Favourable effect of zolpidem on catatonia] (in French). Revue Neurologique, 151, 52-56.
30. McCall, W. V., Mann, S. C., Shelp, F. E., et al (1995) Fatal pulmonary embolism in the catatonic syndrome: two case reports and a literature review. Journal of Clinical Psychiatry, 56, 21-25.
31. Morioka, H., Nagatomo, I., Yamada, K., et al (1997) Deep vein thrombosis of the leg due to psychiatric stupor. Psychiatry and Clinical Neurosciences, 51, 323-326.
32. Moskowitz, A. K. (2004) 'Scared stiff': catatonia as an evolutionary-based fear response. Psychological Review, 111, 984-1002.
33. Northoff, G. (2002) What catatonia can tell us about 'top-down modulation': a neuropsychiatric hypothesis. Behavioural and Brain Sciences, 25, 555-577.
34. Northoff, G., Eckert, J. & Fritze,J. (1997) Glutamatergic dysfunction in catatonia? Successful treatment of three akinetic catatonic patients with the NMDA antagonist amantadine. Journal of Neurology, Neurosurgery and Psychiatry, 62, 404-406.
35. Northoff, G., Lins, H., Boker, H., et al (1999) Therapeutic efficacy of N-methyl-D-aspartate antagonist amantadine in febrile catatonia. Journal of Clinical Psychopharmacology, 19, 484-486.
36. Osman, A. A. & Khurasani, M. H. (1994) Lethal catatonia and neuroleptic malignant syndrome. A dopamine receptor shut-down hypothesis. British Journal of Psychiatry, 165, 548-550.
37. Peralta, V. & Cuesta, M. J. (2001) Motor features in psychotic disorders. II. Development of diagnostic criteria for catatonia. Schizophrenia Research, 47, 117-126.
38. Pfuhlmann, B. & Stober, G. (2001) The different conceptions of catatonia: historical overview and critical discussion. European Archives of Psychiatry and Clinical Neuroscience, 251 (suppl. 1), 14-17.
39. Pommepuy, N. & Januel, D. (2002) [Catatonia: resurgence of a concept. A review of the international literature] (in French). L'Encéphale, 28, 481-492.
40. Raja, M., Altavista, M. C., Cavallari, S., et al (1994) Neuroleptic malignant syndrome and catatonia. A report of three cases. European Archives of Psychiatry and Clinical Neuroscience, 243, 299-303.
41. Reeves, R. R., Torres, R. A., Liberto, V., et al (2002) Atypical neuroleptic malignant syndrome associated with olanzapine. Pharmacotherapy, 22, 641-644.
42. Rohland, B. M., Carroll, B. T. & Jacoby, R. G. (1993) ECT in the treatment of the catatonic syndrome. Journal of Affective Disorders, 29, 255-261.
43. Rosebush, P. I., Hildebrand, A. M., Furlong, B. G., et al (1990) Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. Journal of Clinical Psychiatry, 51, 357-362.
44. Rosebush, P. I., MacQueen, G. M., Clarke, J. T., et al (1995) Late-onset Tay-Sachs disease presenting as catatonic schizophrenia: diagnostic and treatment issues. Journal of Clinical Psychiatry, 56, 347-353.
45. Scott, A. I. F. (2005) College guidelines on electroconvulsive therapy: an update for prescribers. Advances in Psychiatric Treatment, 11, 150-156.
46. Starkstein, S. E., Petracca, G., Teson, A., et al (1996) Catatonia in depression: prevalence, clinical correlates, and validation of a scale. Journal of Neurology, Neurosurgery and Psychiatry, 60, 326-332.
47. Stober, G. (2001) Genetic predisposition and environmental causes in periodic and systematic catatonia. European Archives of Psychiatry and Clinical Neuroscience, 251 (suppl. 1), 121-124.
48. Stober, G., Franzek, E., Haubitz, I., et al (1998) Gender differences and age of onset in the catatonic subtypes of schizophrenia. Psychopathology, 31, 307-312.
49. Stober, G., Seelow, D., Ruschendorf, F., et al (2002) Periodic catatonia: confirmation of linkage to chromosome 15 and further evidence for genetic heterogeneity. Human Genetics, 111, 323-330.
50. Stompe, T., Ortwein-Swoboda, G., Ritter, K., et al (2002) Are we witnessing the disappearance of catatonic schizophrenia? Comprehensive Psychiatry, 43, 167-174.
51. Suzuki, K., Awata, S., Takano, T., et al (2005) Continuation electro-convulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia. Psychiatry and Clinical Neurosciences, 59, 481-489.
52. Taylor, M. A. & Fink, M. (2003) Catatonia in psychiatric classification: a home of its own. American Journal of Psychiatry, 160, 1233-1241.
53. Thomas, C., Carroll, B. T., Maley, R. T., et al (2005) Memantine and catatonic schizophrenia. American Journal of Psychiatry, 162, 626.
54. Ungvari, G. S., Leung, C. M., Wong, M. K., et al (1994a) Benzodiazepines in the treatment of catatonic syndrome. Acta Psychiatrica Scandinavica, 89, 285-288.
55. Ungvari, G. S., Leung, H. C. & Lee, T. S. (1994b) Benzodiazepines and the psychopathology of catatonia. Pharmacopsychiatry, 27, 242-245.
56. Ungvari, G. S., Leung, S. K., Ng, E S., et al (2005) Schizophrenia with prominent catatonic features ('catatonic schizophrenia'). I: Demographic and clinical correlates in the chronic phase. Progress in Neuropsychopharmacology and Biological Psychiatry, 29, 27-38.
57. Van Den Eede, F. & Sabbe, B. (2004) Catatonia in psychiatric classification. American Journal of Psychiatry, 161, 2327-2328.
58. Van Den Eede, E, Van Hecke, J., Van Dalfsen, A., et al (2005) The use of atypical antipsychotics in the treatment of catatonia. European Psychiatry, 20, 422-429.
59. Van der Heijden, F. M., Tuinier, S., Arts, N. J., et al (2005) Catatonia: disappeared or under-diagnosed? Psychopathology, 38, 3-8.
60. White, D. A. & Robins, A. H. (1991) Catatonia: harbinger of the neuroleptic malignant syndrome. British Journal of Psychiatry, 158, 419-421.
61. Wilcox, J. A. (1986) Perinatal distress and infectious disease as risk factors for catatonia. Psychopathology, 19, 196-199.
62. Wilcox, J. A. & Nasrallah, H. A. (1986) Organic factors in catatonia. British Journal of Psychiatry, 149, 782-784.
63. World Health Organization (1992) Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD-10). WHO.
64. Yacoub, A., Kohen, I., Francis, A., et al (2004) Catatonia with thrombotic thrombocytopenic purpura. Psychosomatics, 45, 363-364.
65. Yeh, A. W., Lee, J. W. & Cheng, T. C., et al (2004) Clozapine withdrawal catatonia associated with cholinergic and serotonergic rebound hyperactivity: a case report. Clinical Neuropharmacology, 27, 216-218.